Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic treatment TA1159 3 June 2026 3 June 2026 Durvalumab with chemotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results